Stone, Kidney
33
8
10
13
Key Insights
Highlights
Success Rate
87% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
6.1%
2 terminated out of 33 trials
86.7%
+0.2% vs benchmark
3%
1 trials in Phase 3/4
0%
0 of 13 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 13 completed trials
Clinical Trials (33)
Effect of Preop Stent Duration on SFR and Secondary Intervention in RIRS
Efficacy of Different Modalities on Management of Renal Hard Stones
Mobile Health Platform for Surveillance of Kidney Stone
Comparison Between Two Methods for Renal Stone Treatment Mini Percutaneous Nephrolithotomy and Flexible Ureteroscopy With Suction Sheath
FANS-FURS vs Suction Mini-PCNL for 2-3 cm Renal Stones: A Multicenter Randomized Trial
Stent Omission After Ureteroscopy and Lithotripsy in the Michigan Urological Surgery Improvement Collaborative
Kidney Stone Inflammation
Registry of MIUS for Urolithiasis (ReMIUS-U)
Use of POCUS and STONE Criteria Together in the Diagnosis of Nephrolithiasis
Impact of Surgical Position on Stone-Free Rates in Retrograde Intrarenal Surgery
Evaluation of Retrograde Intra Renal Surgery in the T-tilted Position
Silodosin in Facilitating Flexible Uretroscopy
Effectiveness of Self-posturotherapy on the Elimination of Residual Fragments After Treatment of Lower Calyx Urinary Stones by Extracorporeal Lithotripsy or Retrograde Flexible Ureteroscopy.
Three Dimensional Virtual Reconstruction (3D) in Percutaneous Nephrolithotomy
Homework in Retrograde Intrarenal Surgery
Accuracy of Ultrasound for Detecting Residual Fragments During RIRS
Disposable Versus Disposable Nephroscope During PCNLs: a Feasibility RCT
Evaluation of Novel Disposable Flexible Ureteroscope for the Treatment of Renal Calculi
Silodosin in Management of Lower Ureteral Stones
Effectiveness of Drainage by PCN vs. JJ in Patients With Symptoms of Obstructive Kidney Disease Caused by Urolithiasis